Back to Search
GIULIA TORTORA, MD
MD
Family Medicine Physician
NPI: 1730221078Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
2933(AK)
Research & Publications (20)
Acute inflammatory bowel disease of the small intestine in adult: MDCT findings and criteria for differential diagnosis.
PMID 19144486·Eur J Radiol·2009
6-review
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3.
PMID 18698039·Clin Cancer Res·2008
7-preclinical
Intensive-care unit lung infections: The role of imaging with special emphasis on multi-detector row computed tomography.
PMID 17954020·Eur J Radiol·2008
6-review
Use of chitosan for chromium removal from exhausted tanning baths.
PMID 18725745·Water Sci Technol·2008
8-other
Juvenile and adult immature and in vitro matured ovine oocytes evaluated in relation to membrane electrical properties, calcium stores, IP3 sensitivity and apoptosis occurrence in cumulus cells.
PMID 18404643·Mol Reprod Dev·2008
7-preclinical
The use of xenograft models for the selection of cancer treatments with the EGFR as an example.
PMID 18389522·Crit Rev Oncol Hematol·2008
6-review
Cellular localization of GDNF and its GFRalpha1/RET receptor complex in the developing pancreas of cat.
PMID 19014364·J Anat·2008
7-preclinical
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
PMID 18665191·Br J Cancer·2008
7-preclinical
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells.
PMID 18381602·J Cell Physiol·2008
7-preclinical
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs.
PMID 18319715·Br J Cancer·2008
7-preclinical
Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
PMID 18594498·Nat Clin Pract Oncol·2008
6-review
Infections of the neck leading to descending necrotizing mediastinitis: Role of multi-detector row computed tomography.
PMID 17961947·Eur J Radiol·2008
6-review
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.
PMID 18694994·Clin Cancer Res·2008
8-other
LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
PMID 18413796·Mol Cancer Ther·2008
7-preclinical
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches.
PMID 18089705·Mol Cancer Ther·2007
8-other
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling.
PMID 18045190·Curr Pharm Des·2007
6-review
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
PMID 18024868·J Clin Oncol·2007
3-trial
The exosporium of B. cereus contains a binding site for gC1qR/p33: implication in spore attachment and/or entry.
PMID 17892212·Adv Exp Med Biol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4136 BARTLETT ST, HOMER MEDICAL CLINIC
HOMER, AK 99603 - Phone
- (907) 235-8586
Quick Facts
- NPI
- 1730221078
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile